🔗 Share this article

This year's prestigious award in medical science has been granted for transformative findings that clarify how the immune system attacks harmful pathogens while sparing the body's own cells.

A trio of renowned scientists—from Japan Prof. Sakaguchi and US scientists Mary Brunkow and Dr. Ramsdell—received this honor.

Their research uncovered specialized "sentinels" within the immune system that remove malfunctioning defense cells that could harming the body.

The findings are now paving the way for innovative treatments for autoimmune diseases and cancer.

The winners will share a monetary award valued at 11m Swedish kronor.

Crucial Discoveries

"The research has been essential for comprehending how the immune system functions and why we don't all develop severe autoimmune diseases," stated the chair of the Nobel Committee.

This trio's studies explain a core mystery: How does the defense system protect us from countless invaders while leaving our healthy cells intact?

Our immune system uses white blood cells that scan for signs of disease, even viruses and bacteria it has never encountered.

These defenders utilize sensors—known as recognition units—that are generated randomly in a vast number of combinations.

This provides the defense network the ability to combat a broad range of threats, but the randomness of the process unavoidably creates immune cells that may target the host.

Protectors of the Immune System

Scientists previously knew that a portion of these problematic defense cells were destroyed in the thymus—the site where white blood cells mature.

The latest Nobel Prize honors the discovery of T-reg cells—known as the body's "security guards"—which travel through the body to disarm any defenders that attack the healthy cells.

It is known that this mechanism fails in self-attack conditions such as type-1 diabetes, MS, and RA.

The Nobel panel added, "These findings have laid the foundation for a new field of investigation and spurred the development of innovative therapies, for instance for tumors and immune disorders."

In malignancies, regulatory T-cells prevent the body from fighting the tumor, so research are aimed at reducing their numbers.

In autoimmune diseases, trials are exploring boosting T-reg cells so the organism is no longer being harmed. A similar method could also be useful in reducing the chances of organ transplant rejection.

Innovative Experiments

Professor Shimon Sakaguchi, from a Japanese institution, performed experiments on rodents that had their immune gland removed, causing self-attack conditions.

The researcher showed that injecting immune cells from healthy animals could prevent the illness—implying there was a mechanism for preventing immune cells from attacking the body.

Dr. Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an inherited autoimmune disease in mice and humans that led to the identification of a genetic factor critical for how T-regs operate.

"Their groundbreaking research has revealed how the immune system is controlled by regulatory T cells, preventing it from mistakenly targeting the body's own tissues," said a prominent physiology specialist.

"This work is a remarkable example of how fundamental physiological study can have far-reaching consequences for human health."